Aspen Group Reports 81% Revenue Growth and Positive Net

New Post Public Reply Private Reply Replies (0) Message Board
News Desk 2018
Aspen Group Reports 81% Revenue Growth and Positive Net Income in the Fiscal 2017 Second Quarter

NEW YORK, Dec. 12, 2016 (GLOBE NEWSWIRE) -- Aspen Group, Inc. (OTCQB:ASPU) (“Aspen”), a nationally accredited online post-secondary education company (Aspen University), today announced financial results for its 2017 fiscal second quarter ended October 31, 2016. The Company will host a conference call to discuss its financial results on Monday, December 12, 2016, at 4:30 p.m. (ET). 

“I’d like to take this opportunity to congratulate all of Aspen’s operational constituencies; including faculty, academic operations, technology, enrollment, and management, on achieving profitability on a Net Income basis,” said Chairman & CEO, Michael Mathews.  “We’ve always been convinced that our dedication to providing a high-quality, affordable distance learning education to working professionals, and Registered Nurses in particular, would deliver profitability at scale. That day has arrived, and we’re excited to continue scaling our monthly payment method business model for the benefit of tens of thousands more working professionals in the years to come,” continued Mathews.

Fiscal 2017 Second Quarter Highlights:

  • Revenue totaled $3,465,026, an increase of 81% as compared to the same period the prior year;
  • GAAP Gross Profit totaled $2,101,373, a 130% increase as compared to the same period the prior year;
  • Operating Income totaled $171,512 or 5% margin, a 124% increase as compared to the same period the prior year;
  • Net Income applicable to shareholders of $116,541 or 3% margin, as compared to a Net Loss of ($744,420) for the same period the prior year, an improvement of 116%;
  • EBITDA, a non-GAAP financial measure, totaled $310,517 or 9% margin, a 155% improvement from the comparable prior year period;
  • Adjusted EBITDA, a non-GAAP financial measure, totaled $469,629 or 14% margin, a 268% improvement from the comparable prior year period;
  • As previously announced, Aspen set a quarterly enrollment record in the second quarter with 811 new student enrollments, as compared to 557 new student enrollments in the prior year, an increase of 46% year-over-year.

Fiscal 2017 Second Quarter Financial Results: For the second quarter, revenues increased 81% to $3,465,026 as compared to $1,913,161 for the same period the prior year. 

GAAP Gross Profit increased to $2,101,373 or 61% Gross Margin. The 61% GAAP Gross Margin result represents a 1,300 basis point improvement year-over-year, based on instructional costs and marketing costs each rising year-over-year by only 42%.

General and Administrative costs were $1,919,653 as compared to $1,610,202 for the same period the prior year, an increase of $309,451 or 19%. From a sequential perspective, excluding the one-time, non-recurring expenses incurred in the July 30, 2016 quarter of $269,000 (warrant extinguishment and litigation settlement), General and Administrative costs rose by only $12,575 quarter-over-quarter.

Operating income was $171,512 or 5% margin, a 124% improvement from the comparable prior year period. Cash provided from operations for the six months ended October 31, 2016 was $26,323, a 103% improvement from the comparable prior year period.

Net Income applicable to shareholders was $116,541 or 3% margin, a 116% improvement from the comparable prior year period. EBITDA, a non-GAAP financial measure, was $310,517 or 9% margin, a 155% improvement from the comparable prior year period. Adjusted EBITDA, a non-GAAP financial measure, was $469,629 or 14% margin, a 268% improvement from the comparable prior year period.

The following table presents a reconciliation of Adjusted EBITDA to Net loss, a GAAP financial measure:

 
  For the Three Months Ended
  October 31,
    2016     2015  
Net Income (Loss) $ 116,541   $ (744,420 )
Interest expense, net of income   54,971     31,320  
Depreciation and amortization   139,005     148,258  
EBITDA (Loss)   310,517     (564,842 )
Bad debt expense   -     67,299  
Stock-based compensation   61,728     56,046  
Non-Recurring and Other expenses*   97,384     162,145  
Adjusted EBITDA (Loss) $ 469,629   $ (279,352 )
             

Conference Call: Aspen Group, Inc. will host a conference call to discuss its October 31, 2016 fiscal year 2017 second quarter financial results and business outlook on Monday, December 12, 2016, at 4:30 p.m. (ET). The conference call can be accessed by dialing toll-free (844) 452-6823 (U.S.) or (731) 256-5216 (international).  Subsequent to the call, a transcript of the audiocast will be available from the Company’s website at ir.aspen.edu .

About Aspen Group, Inc.: Aspen Group, Inc. is an online postsecondary education company. Aspen University’s mission is to offer any motivated college-worthy student the opportunity to receive a high quality, responsibly priced distance-learning education for the purpose of achieving sustainable economic and social benefits for themselves and their families. Aspen is dedicated to providing the highest quality education experiences taught by top-tier faculty - 57% of our faculty hold doctoral degrees. To learn more about Aspen, visit www.aspen.edu .

* Non-GAAP – Financial Measures This press release includes both financial measures in accordance with Generally Accepted Accounting Principles, or GAAP, as well as non-GAAP financial measures. Generally, a non-GAAP financial measure is a numerical measure of a company’s performance, financial position or cash flows that either excludes or includes amounts that are not normally included or excluded in the most directly comparable measure calculated and presented in accordance with GAAP. Non-GAAP financial measures should be viewed as supplemental to, and should not be considered as alternatives to net income, operating income, and cash flow from operating activities, liquidity or any other financial measures. They may not be indicative of the historical operating results of Aspen Group nor are they intended to be predictive of potential future results. Investors should not consider non-GAAP financial measures in isolation or as substitutes for performance measures calculated in accordance with GAAP.

Our management uses and relies on Adjusted EBITDA and EBITDA, each of which are non-GAAP financial measures. The line identified as ‘non-recurring and other expenses’ includes non-recurring expenses and other expenses which do not reflect the core nature of our operations. We believe that both management and shareholders benefit from referring to the following non-GAAP financial measures in planning, forecasting and analyzing future periods. Our management uses these non-GAAP financial measures in evaluating its financial and operational decision making and as a means to evaluate period-to-period comparison.  Our management recognizes that the non-GAAP financial measures have inherent limitations because of the excluded items described below.

Aspen Group defines Adjusted EBITDA as earnings (or loss) from continuing operations before the items in the table above. Aspen Group excludes these expenses because they are non-cash or non-recurring in nature or otherwise not reflective of our core business.

We have included a reconciliation of our non-GAAP financial measures to the most comparable financial measures calculated in accordance with GAAP. We believe that providing the non-GAAP financial measures, together with the reconciliation to GAAP, helps investors make comparisons between Aspen Group and other companies. In making any comparisons to other companies, investors need to be aware that companies use different non-GAAP measures to evaluate their financial performance. Investors should pay close attention to the specific definition being used and to the reconciliation between such measure and the corresponding GAAP measure provided by each company under applicable SEC rules.

Company Contact: Aspen Group, Inc. Michael Mathews, CEO 914-906-9159 Investor Contact: Capital Markets Group, LLC PH: (914) 669-0222 info@CapMarketsGroup.com www.CapMarketsGroup.com

Scroll down for more posts ▼

Top 10 Most Recent News Articles

Ambrosia Biosciences Unveils Promising Nonclinical Metabolic Data

Updated Category News Views 255

Ambrosia's Latest Nonclinical Revelations Ambrosia Biosciences has just thrown out some major bait at ObesityWeek® 2026. The highlight? New nonclinical data profiles for two of their understudy small molecule programs—AMB-895 and AMB-131. It may sound niche, but in this sector, promising data spins heads. Their GLP-1 receptor agonist, AMB-895, and GIP receptor...

Continue Reading
Princess Cruises Launches New Era at Celebration Key

Updated Category News Views 153

Never thought I'd see the day when a cruise ship docking would stir such excitement, but here we are. The Star Princess has made its grand debut at Celebration Key, the latest jewel in Princess Cruises' crown. And they're going all out with Bahamian flair—something about a Junkanoo band and beach art that would make even the crustiest sailor crack a smile. Inaugural Fun...

Continue Reading
Uber Data Breach: Class Action Investigation Begins

Updated Category News Views 258

When Tech Meets Trouble: Uber's Data Breach Picture this: the hum of Uber rides weaving through your city, drivers none the wiser that personal info has been pried from the vaults thanks to their tech partner, Fireworks AI. Uber, folks, is in hot water once again. This isn’t just another tech hiccup; it's a legal whirlwind brewing up courtesy of Edelson Lechtzin LLP, a...

Continue Reading
D-Wave Quantum Hit with Securities Fraud Lawsuit

Updated Category News Views 314

A Legal Quagmire for D-Wave Quantum Investors Securities fraud lawsuits are like light in a dark alley—you need them when the truth's been stashed out of sight, but they illuminate the dirty and damp parts of investment strategies nobody wants to talk about. Right now, D-Wave Quantum Inc. is smack dab in the middle of such litigious action. If you had the misfortune of...

Continue Reading
KINGRVER Boosts RV Comfort with New Water Heater Lineup

Updated Category News Views 190

An Upgrade for the Open Road In the land of RV living, comfort is king—or in this case, KINGRVER. Dropping affordable upgrades for water heaters into the world of RVs, KINGRVER's CT6 lineup is like a warm hug on a chilly campsite morning. Whether you've pulled up to a wooded retreat or parked under the vast desert sky, having dependable hot water shouldn't be a gamble....

Continue Reading
Shenzhen's Vision Unveiled: APEC 2026 Promo Debut

Updated Category News Views 410

Shenzhen's Spotlight Moment at APEC 2026 When Shenzhen announced its promotional video for the 2026 APEC Economic Leaders' Meeting, it wasn't just about standard tourism glitz. This was a show of force, a bold step onto the main stage of global politics and economics. The video's launch wasn’t merely an audio-visual delight—it staked a claim in shaping the future...

Continue Reading
Championing Change: USTA Mid-Atlantic Gala's Impact

Updated Category News Views 262

A Night to Remember: USTA Mid-Atlantic's Gala Who would've thought tennis could wield such transformative power? This ain't your average sport gala. Last Saturday, a crowd of over 300 gathered at the Ritz-Carlton Tysons Corner for the USTA Mid-Atlantic Foundation's 2026 Tennis Creates Gala. Hosted by the formidable Malika Andrews, this event wasn't just a fancy...

Continue Reading
Pan-Mass Challenge Gifts $80M to Dana-Farber for 2026

Updated Category News Views 63

A Momentous Gift in a Crunch Time for Cancer Research Biking and philanthropy might seem like an odd duo, but let me tell you, the Pan-Mass Challenge (PMC) is making that partnership look like peanut butter and jelly. This year, PMC rolled out a jaw-dropping $80 million gift to the Dana-Farber Cancer Institute. You heard right—eighty million smackeroos. Talk about going...

Continue Reading
Novo's CagriSema Trials Show Promising Weight Loss

Updated Category News Views 220

Decoding CagriSema's Promise Let me tell you, when those corporate folks from Novo Nordisk announce something big like their investigational drug CagriSema at ObesityWeek® 2026, it’s time to take notice. This isn’t just your average press release about some new weight loss fad. We’re talking about a phase 3 REDEFINE 1 trial that opens up a treasure chest of data...

Continue Reading
JOYEE N01 Debuts Globally with First 2,000 Deliveries

Updated Category News Views 271

JOYYE N01 Breaks into the Global Market Now, here we go, folks—a Chinese car with ambitions bigger than the Sahara. On October 28, the JOYEE N01 rolled off the assembly line and into the international scene with a lot of fanfare at FAW's Yancheng Branch. Mark my words, this isn't just another model trying to strut into the global auto arena. This event delivered the...

Continue Reading

Top 5 Most Recently Viewed Articles

Elis Announces Share Buyback Operations Details and Impact

Updated Category News Views 257

Elis Announces Share Buyback Operations Recent Trading Disclosure by Elis In alignment with European regulations governing share buybacks, Elis has disclosed transactions for the purchase of its own shares. These operations occurred from September 15 to September 19, 2025, as part of an authorized buyback program approved by the General Shareholders' Meeting earlier in...

Continue Reading
One Stop Systems Set To Showcase Innovations at ROTH Event

Updated Category News Views 122

One Stop Systems Announces Participation in Major Conference One Stop Systems, Inc. (OSS), renowned for its cutting-edge solutions in rugged Enterprise Class computing, is gearing up to engage with investors at a prominent industry event. This year, OSS will be present at the 37th Annual ROTH Conference, scheduled for mid-March. The event will serve as a platform for the...

Continue Reading
Solid Biosciences to Engage at BioPharma Symposium Soon

Updated Category News Views 80

Solid Biosciences to Participate at BioPharma Symposium Solid Biosciences Inc. (NASDAQ: SLDB), a pioneering life sciences company, is excited to announce a significant upcoming event where they will showcase their advancements in the field of precision genetic medicine. The company's Chief Medical Officer, Dr. Gabriel Brooks, is scheduled to participate in a Genetic...

Continue Reading
JD Vance Confronted by Protesters While Out with Daughter

Updated Category News Views 378

Intense Encounter for Vice President JD Vance Recently, Vice President JD Vance found himself in a challenging situation when he was confronted by a group of pro-Ukraine protesters while spending time with his daughter. This encounter, which took place in Ohio, captured not only the essence of political tensions but also brought forth the complexities of personal moments...

Continue Reading
Exciting Addition to MyCardiologist as Dr. Koshy Joins Team

Updated Category News Views 325

New Addition to MyCardiologist Enhances Cardiovascular Care MyCardiologist, a leading name in advanced cardiovascular care, proudly announces the joining of Dr. Linda Koshy to their reputable medical team. Dr. Koshy is a skilled general and interventional cardiologist known for her exceptional ability to manage intricate coronary artery disease as well as endovascular...

Continue Reading